A TQT Study to Evaluate the Electrocardiographic Effects of Carbidopa in Healthy Subjects

NCT06161220 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Repolarization in Healthy Subjects

Interventions

DRUG: Carbidopa capsule
DRUG: Moxifloxacin Tablets, USP
DRUG: Placebo

Sponsor

Impax Laboratories, LLC